Biopharmaceuticals

Biopharmaceuticals are substances produced with biotechnology (using live cells), harvested from living organisms. Their high efficacy makes them the future of modern pharmacotherapy.

Biopharmaceuticals

How are biopharmaceuticals produced in bioreactors? What makes them different from traditional drugs made via chemical synthesis? What is the ...

Read full

What dormant power lies in stem cells? How to unleash this power?   Thus far, MSCs have remained unavailable for veterinary therapies. By ...

Read full

What are the differences between pharmaceuticals produced via chemical synthesis and stem cell-based biopharmaceuticals? Why is the efficacy and ...

Read full

What has science yet to discover about the mechanisms of action of MSCs? Is it possible to replace living stem cells without sacrificing the ...

Read full

Our technology for manufacturing MSC-based medicinal products for veterinary use utilises the therapeutic potential of safe allografts (one donor ...

Read full

Wrote about us

Bioceltix is ​​working on drugs based on stem cells for animals [interview]

MamStartup: Bioceltix is a biotech startup that does business in the veterinary industry – the company focuses on developing stem-cell-based biopharmaceuticals.  These biopharmaceuticals are a safer as well as more effective alternative to synthetic drugs, which treat only symptoms, not ...

Article

Innowacje na start: Chivas Venture and Bioceltix

We hope you had a chance to tune in to „Radio dla Ciebie” during the „Let’s start with Innovation” („Innowacje na start”) show – that’s for coverage of Chivas Ventures. The forth edition of this contest for startups that are socially involved has now come, gone and guess what? The jury ...

Article

Another round of the prestigious contest designed for social-involved startups – Chivas Venture–  is behind us. We are among the five companies that, on January 17th 2019, will take part in the grand finale of the contest – which is happening in Warsaw. That mid-January ...

Article

Łukasz Bzdzion talks biopharmaceuticals for animals on Polish Radio

The CEO of Bioceltix, Łukasz Bzdion, during an interview for Channel 4 of Polish Radio, answered question regarding the possibility of treating animals using stem-cell-baed biopharmaceuticals and more. The interview starts in the 37th minute.   

Article

(Un)limited stem cells

biotechnologia.pl: Poland is among the countries where innovative biopharmaceuticals re being designed to treat household animals. Bioceltix is developing MSC-based medicines for dogs, horses and cats. The biopharmaceuticals, which are made in Poland, utilise the anti-inflammatory and ...

Article